References
- Gupta A, Madhavan MV, Sehgal K, Nair N, Mahajan S, Sehrawat TS,
Bikdeli B, Ahluwalia N, Ausiello JC, Wan EY, Freedberg DE et al.
Extrapulmonary manifestations of COVID-19. Nat Med. 2020;26:1017-1032.
- Goldenberg NA, Sochet A, Albisetti M, Biss T, Bonduel M, Jaffray J,
MacLaren G, Monagle P, O’Brien S, Raffini L, et al.;
Pediatric/Neonatal Hemostasis and Thrombosis Subcommittee of the ISTH
SSC. Consensus-based clinical recommendations and research priorities
for anticoagulant thromboprophylaxis in children hospitalized for
COVID-19-related illness. J Thromb Haemost. 2020;18:3099-3105.
- Loi M, Branchford B, Kim J, Self C, Nuss R. COVID-19 anticoagulation
recommendations in children. Pediatr Blood Cancer. 2020;67:e28485.
- Mathuria JP, Yadav R, Rajkumar. Laboratory diagnosis of SARS-CoV-2 - A
review of current methods. J Infect Public Health. 2020;13(7):901-905.
- Kotula JJ, Balakumar N, Khan D, Patel B. Bilateral pulmonary emboli in
a teenager with positive SARS-CoV-2 antibody. Pediatr Pulmonol.
2021;56:271-273.
- Martinelli I, Ferrazzi E, Ciavarella A, Erra R, Iurlaro E, Ossola M,
Lombardi A, Blasi F, Mosca F, Peyvandi F. Pulmonary embolism in a
young pregnant woman with COVID-19. Thromb Res. 2020;191:36-37
- Hussain Z, Wangmo R, Gonbo S. Deep Vein Thrombosis After Trivial Blunt
Trauma at High Altitude in a SARS-CoV-2 Positive Child: Complication
of the Hypercoagulable State. Indian Pediatr. 2020;57:1182-1183
- Klok FA, Kruip MJHA, van der Meer NJM, Arbous MS, Gommers DAMPJ, Kant
KM, Kaptein FHJ, van Paassen J, Stals MAM, Huisman MV et al. Incidence
of thrombotic complications in critically ill ICU patients with
COVID-19. Thromb Res. 2020;191:145-147.
- Iba T, Levy JH, Levi M, Connors JM, Thachil J. Coagulopathy of
Coronavirus Disease 2019. Crit Care Med. 2020;48:1358-1364..
- Middeldorp S, Coppens M, van Haaps TF, Foppen M, Vlaar AP, Müller MCA,
Bouman CCS, Beenen LFM, Kootte RS, Heijmans J et al. Incidence of
venous thromboembolism in hospitalized patients with COVID-19. J
Thromb Haemost. 2020;18:1995-2002.
- Thachil J, Srivastava A. SARS-2 Coronavirus-Associated Hemostatic Lung
Abnormality in COVID-19: Is It Pulmonary Thrombosis or Pulmonary
Embolism? Semin Thromb Hemost. 2020;46:777-780.
- Wit JM, Hero M, Nunez SB. Aromatase inhibitors in pediatrics. Nat Rev
Endocrinol. 2011;8:135-47.
- Baum M, Buzdar A, Cuzick J, Forbes J, Houghton J, Howell A, Sahmoud T;
ATAC (Arimidex, Tamoxifen Alone or in Combination) Trialists’ Group.
Anastrozole alone or in combination with tamoxifen versus tamoxifen
alone for adjuvant treatment of postmenopausal women with early-stage
breast cancer: results of the ATAC (Arimidex, Tamoxifen Alone or in
Combination) trial efficacy and safety update analyses. Cancer.
2003;98:1802-10.
- Diaz-Thomas A, Shulman D. Use of aromatase inhibitors in children and
adolescents: what’s new? Curr Opin Pediatr. 2010;22:501-7.
- Zhou B, She J, Wang Y, Ma X. Venous thrombosis and arteriosclerosis
obliterans of lower extremities in a very severe patient with 2019
novel coronavirus disease: a case report. J Thromb Thrombolysis.
2020;50:229-232.
- Franch-Llasat D, Mayor-Vázquez E, Pedregosa-Díaz J, Herrero-Redondo M,
Ortin-Font X, Roche-Campo F. e-Thrombosis in the COVID-19 era:
collateral effects of confinement. Med Intensiva (Engl Ed).
2021;45:122-124.
- Abou-Ismail MY, Diamond A, Kapoor S, Arafah Y, Nayak L. The
hypercoagulable state in COVID-19: Incidence, pathophysiology, and
management. Thromb Res. 2020 Oct;194:101-115.
- Colling ME, Kanthi Y. COVID-19-associated coagulopathy: An exploration
of mechanisms. Vasc Med. 2020;25:471-478
- Jayarangaiah A, Kariyanna PT, Chen X, Jayarangaiah A, Kumar A.
COVID-19-Associated Coagulopathy: An Exacerbated Immunothrombosis
Response. Clin Appl Thromb Hemost. 2020;26:1076029620943293.
- Pons S, Fodil S, Azoulay E, Zafrani L. The vascular endothelium: the
cornerstone of organ dysfunction in severe SARS-CoV-2 infection. Crit
Care. 2020;24:353
- Varga Z, Flammer AJ, Steiger P, Haberecker M, Andermatt R, Zinkernagel
AS, Mehra MR, Schuepbach RA, Ruschitzka F, Moch H. Endothelial cell
infection and endotheliitis in COVID-19. Lancet. 2020;395:1417-1418.
- Müller MM, Griesmacher A. Markers of endothelial dysfunction. Clin
Chem Lab Med. 2000;38:77-85.
- Rauch A, Labreuche J, Lassalle F, Goutay J, Caplan M, Charbonnier L,
Rohn A, Jeanpierre E, Dupont A, Duhamel A et al. Coagulation
biomarkers are independent predictors of increased oxygen requirements
in COVID-19. J Thromb Haemost. 2020;18:2942-2953
- Levi M, Iba T. COVID-19 coagulopathy: is it disseminated intravascular
coagulation? Intern Emerg Med. 2021;16:309-312.
- Iba T, Levy JH, Connors JM, Warkentin TE, Thachil J, Levi M. The
unique characteristics of COVID-19 coagulopathy. Crit Care.
2020;24:360.
- Gazzaruso C, Paolozzi E, Valenti C, Brocchetta M, Naldani D, Grignani
C, Salvucci F, Marino F, Coppola A, Gallotti P. Association between
antithrombin and mortality in patients with COVID-19. A possible link
with obesity. Nutr Metab Cardiovasc Dis. 2020;30:1914-1919.
- Maldonado E, Tao D, Mackey K. Antithrombotic Therapies in COVID-19
Disease: a Systematic Review. J Gen Intern Med. 2020;35:2698-2706.
- Lippi G, Henry BM, Sanchis-Gomar F. Plasma Antithrombin Values Are
Significantly Decreased in Coronavirus Disease 2019 (COVID-19)
Patients with Severe Illness. Semin Thromb Hemost. 2021;47:460-462.